On ceramides, other sphingolipids and impaired glucose homeostasis
about
Glucose induces sensitivity to oxygen deprivation and modulates insulin/IGF-1 signaling and lipid biosynthesis in Caenorhabditis elegans.Lipidomics-Reshaping the Analysis and Perception of Type 2 DiabetesHumoral Dysregulation Associated with Increased Systemic Inflammation among Injection Heroin UsersGlucose or Altered Ceramide Biosynthesis Mediate Oxygen Deprivation Sensitivity Through Novel Pathways Revealed by Transcriptome Analysis in Caenorhabditis elegans.Development and validation of an HPLC-MS method for the simultaneous quantification of key oxysterols, endocannabinoids, and ceramides: variations in metabolic syndrome.Acid sphingomyelinase deficiency in Western diet-fed mice protects against adipocyte hypertrophy and diet-induced liver steatosis.Association between Plasmatic Ceramides Profile and AST/ALT Ratio: C14:0 Ceramide as Predictor of Hepatic Steatosis in Adolescents Independently of ObesityEfficacy of nutritional interventions to lower circulating ceramides in young adults: FRUVEDomic pilot studyCarnitine Palmitoyltransferase 1b Deficient Mice Develop Severe Insulin Resistance After Prolonged High Fat Diet Feeding.Glucose and palmitate uncouple AMPK from autophagy in human aortic endothelial cellsHigh fat diet-induced modifications in membrane lipid and mitochondrial-membrane protein signatures precede the development of hepatic insulin resistance in miceInterictal, circulating sphingolipids in women with episodic migraine: A case-control study.Endurance and Resistance Training Affect High Fat Diet-Induced Increase of Ceramides, Inflammasome Expression, and Systemic Inflammation in Mice.The use of metabolic profiling to identify insulin resistance in veal calvesAssociations of anthropometric markers with serum metabolites using a targeted metabolomics approach: results of the EPIC-potsdam studyAlterations of specific lipid groups in serum of obese humans: a review.A Healthy Nordic Diet Alters the Plasma Lipidomic Profile in Adults with Features of Metabolic Syndrome in a Multicenter Randomized Dietary Intervention.Intramyocellular Ceramides: Subcellular Concentrations and Fractional De Novo Synthesis in Postabsorptive Humans.Implication of Ceramide Kinase in Adipogenesis.Short Term Palmitate Supply Impairs Intestinal Insulin Signaling via Ceramide Production.Effect of carnosine supplementation on the plasma lipidome in overweight and obese adults: a pilot randomised controlled trial.Effects of meal ingestion on intramyocellular ceramide concentrations and fractional de novo synthesis in humans.Effects of Quercetin in a Rat Model of Hemorrhagic Traumatic Shock and Reperfusion.Types A and B Niemann-Pick disease.Alterations of plasma metabolite profiles related to adipose tissue distribution and cardiometabolic risk.The small-molecule BGP-15 protects against heart failure and atrial fibrillation in mice.Metabolomics for Biomarkers of Type 2 Diabetes Mellitus: Advances and Nutritional Intervention TrendsType 2 diabetes mellitusEvaluation of serum sphingolipids and the influence of genetic risk factors in age-related macular degeneration
P2860
Q27346465-41AC51DA-00AF-43C7-A4D3-835EC28139E7Q28073169-D8196E15-C053-41BA-8830-54510A200223Q28552355-5FEFD8F6-B0C5-4293-8B2E-E700CB6F2716Q30823934-5753C109-6A1B-448F-B7B0-81CEC1B1BB81Q33466544-1302577A-C35B-499D-BA3F-6F275F3786AAQ33600495-71E9A364-D199-44B7-B622-CD7AB5A6621BQ33786729-E87595EE-61C0-4FC7-94A5-B2AF6206EEF5Q33896092-8867BC9D-23DC-42BD-8843-716F0A1A0A9CQ34858404-B41BB00A-0683-4063-9BEC-B47C2AE6DB9DQ35034843-F29989ED-CB29-4794-BB66-5B3E9A35EBCDQ35040495-7021C7C3-D543-4106-B31C-FB744E5AD884Q36166971-1317846A-9882-433B-A2C6-AC91B56810A9Q36405704-C71F247D-F064-4A9E-B807-A9D585DA04CDQ36406379-916CB6ED-A340-4729-8E88-8C957D7FCCD7Q37061182-3F69738E-13B6-4939-980F-45D2AF01B78CQ39023727-57EE31C0-92BD-4DBF-94B8-7BCC7FCB1C6DQ39932794-31CB229B-A429-417F-8216-B12923BB5B06Q40209806-2D10D4DE-0A16-4AD8-8426-0E2045E7A829Q41689622-E33FDA25-58D8-4526-AD39-1E497D4764A1Q42395469-090DCCA6-19D2-4DC9-84D8-FFF64B50570CQ47134650-E589001F-9C1A-4376-B08B-4B47BCCD3E4EQ47879924-20077F71-6C58-4E6A-B4E2-DF69241C18AFQ50220852-F383020A-3EE0-4A86-AF57-A8D0BA795C1CQ52323810-9764B534-1161-4BA6-BA57-6A6EF639E76FQ53367555-F0E53A0A-BBF5-4502-8EFC-F2E044EEA929Q55069411-6FCCEAA4-087F-451E-9003-AE924ED3D7D0Q58419488-B236A7AC-9804-4589-8B60-AA3E193609A6Q58447602-CB80749D-74DC-4DDB-ABB3-F98CA32B41C0Q58803874-3264FFB6-28D9-4AD9-AA37-71EB4B55908E
P2860
On ceramides, other sphingolipids and impaired glucose homeostasis
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
On ceramides, other sphingolipids and impaired glucose homeostasis
@ast
On ceramides, other sphingolipids and impaired glucose homeostasis
@en
On ceramides, other sphingolipids and impaired glucose homeostasis
@nl
type
label
On ceramides, other sphingolipids and impaired glucose homeostasis
@ast
On ceramides, other sphingolipids and impaired glucose homeostasis
@en
On ceramides, other sphingolipids and impaired glucose homeostasis
@nl
prefLabel
On ceramides, other sphingolipids and impaired glucose homeostasis
@ast
On ceramides, other sphingolipids and impaired glucose homeostasis
@en
On ceramides, other sphingolipids and impaired glucose homeostasis
@nl
P2860
P3181
P1433
P1476
On ceramides, other sphingolipids and impaired glucose homeostasis
@en
P2093
Norbert Tennagels
Philip J. Larsen
P2860
P304
P3181
P356
10.1016/J.MOLMET.2014.01.011
P407
P577
2014-06-01T00:00:00Z